IL207913A - Nano-emulsion that undergoes lipophilization - Google Patents

Nano-emulsion that undergoes lipophilization

Info

Publication number
IL207913A
IL207913A IL207913A IL20791310A IL207913A IL 207913 A IL207913 A IL 207913A IL 207913 A IL207913 A IL 207913A IL 20791310 A IL20791310 A IL 20791310A IL 207913 A IL207913 A IL 207913A
Authority
IL
Israel
Prior art keywords
lyophilised nanoemulsion
nanoemulsion
lyophilised
Prior art date
Application number
IL207913A
Other languages
English (en)
Hebrew (he)
Other versions
IL207913A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL207913A0 publication Critical patent/IL207913A0/en
Publication of IL207913A publication Critical patent/IL207913A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL207913A 2008-03-20 2010-08-31 Nano-emulsion that undergoes lipophilization IL207913A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008015366A DE102008015366A1 (de) 2008-03-20 2008-03-20 Lyophilisierte Nanoemulsion
PCT/EP2009/001355 WO2009115175A2 (de) 2008-03-20 2009-02-26 Lyophilisierte nanoemulsion

Publications (2)

Publication Number Publication Date
IL207913A0 IL207913A0 (en) 2010-12-30
IL207913A true IL207913A (en) 2015-05-31

Family

ID=40984061

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207913A IL207913A (en) 2008-03-20 2010-08-31 Nano-emulsion that undergoes lipophilization

Country Status (9)

Country Link
US (1) US8211948B2 (enExample)
EP (1) EP2252267B1 (enExample)
JP (1) JP5603852B2 (enExample)
AU (1) AU2009226618B2 (enExample)
CA (1) CA2718791C (enExample)
DE (1) DE102008015366A1 (enExample)
ES (1) ES2608062T3 (enExample)
IL (1) IL207913A (enExample)
WO (1) WO2009115175A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357639B2 (en) * 2007-07-03 2013-01-22 Baker Hughes Incorporated Nanoemulsions
DK2268160T3 (da) 2008-03-20 2013-01-07 Virun Inc Emulsioner omfattende et PEG-derivat af tokoferol
EP2268274B1 (en) 2008-03-20 2012-05-16 Virun, Inc. Vitamin e derivatives and their uses
EP2563164B1 (en) 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsion including sucrose fatty acid ester
US8741373B2 (en) 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
US8586527B2 (en) 2011-10-20 2013-11-19 Jaipal Singh Cerivastatin to treat pulmonary disorders
DK2806877T3 (da) 2012-01-23 2019-11-04 Sage Therapeutics Inc Neuroaktive steroidformuleringer omfattende et kompleks af allopregnanolon og sulfobutylether beta-cyclodekstrin
WO2013120025A1 (en) 2012-02-10 2013-08-15 Virun, Inc. Beverage compositions containing non-polar compounds
CA2882708A1 (en) 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
MX2021006750A (es) * 2018-12-06 2021-11-17 Lipicare Life Sciences Ltd Nanoemulsiones de vitamina d y usos de las mismas.
JP7756548B2 (ja) * 2021-11-30 2025-10-20 株式会社ダイセル ガス発生器
CN116650425B (zh) * 2023-07-13 2025-06-27 晟迪生物医药(苏州)有限公司 糖酯化合物或其盐在冷冻保护、冷冻干燥保护中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5296724A (en) 1976-02-10 1977-08-13 Kyowa Hakko Kogyo Co Ltd Preparation of powdery products
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
JPH04275216A (ja) * 1991-03-04 1992-09-30 Eisai Co Ltd 脂溶性薬物を含有した凍結乾燥組成物
DE4244122C1 (de) 1992-12-24 1994-06-01 Sanol Arznei Schwarz Gmbh Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
US5646082A (en) 1993-06-24 1997-07-08 Cosmo Research Institute Crystalline aluminosilicate, process for producing the same, and catalyst employing the same for catalytic cracking of hydrocarbon oil
US5948002A (en) * 1996-11-15 1999-09-07 Bonutti; Peter M. Apparatus and method for use in positioning a suture anchor
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JPH11171796A (ja) 1997-12-08 1999-06-29 Ohta Pharmaceut Co Ltd テプレノン経口投与用製剤およびその製造方法
FR2800611B1 (fr) * 1999-11-08 2002-10-11 Oreal Composition a application topique contenant un sucre, et ses utilisations cosmetiques
WO2002087692A1 (en) * 2001-04-26 2002-11-07 The Procter & Gamble Company A method and apparatus for the treatment of cosmetic skin conditioins
JP2004161650A (ja) 2002-11-12 2004-06-10 Taisho Pharmaceut Co Ltd Ｗ／ｏ／ｗ型ドライエマルション
EP1598060A1 (en) * 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
WO2006134970A1 (ja) * 2005-06-15 2006-12-21 Kaneka Corporation コエンザイムｑ１０含有水溶性組成物及びその製法
FR2901124B1 (fr) * 2006-05-17 2008-06-27 Oreal Emulsion huile dans eau fine
JP2008142588A (ja) * 2006-12-06 2008-06-26 Fujifilm Corp 水中油滴型エマルション及びその製造方法、並びに機能性粉末及びその製造方法
CN101428002A (zh) * 2008-11-20 2009-05-13 沈阳万爱普利德医药科技有限公司 注射用紫杉醇冻干微乳剂及其制备方法

Also Published As

Publication number Publication date
WO2009115175A2 (de) 2009-09-24
ES2608062T3 (es) 2017-04-05
AU2009226618B2 (en) 2014-04-10
US8211948B2 (en) 2012-07-03
CA2718791C (en) 2016-03-29
US20110015266A1 (en) 2011-01-20
EP2252267B1 (de) 2016-09-28
JP2011519349A (ja) 2011-07-07
CA2718791A1 (en) 2009-09-24
WO2009115175A3 (de) 2010-01-07
IL207913A0 (en) 2010-12-30
EP2252267A2 (de) 2010-11-24
JP5603852B2 (ja) 2014-10-08
DE102008015366A1 (de) 2009-09-24
AU2009226618A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
IL207913A0 (en) Lyophilised nanoemulsion
GB2504633B (en) Nanoemulsions
ZA200903468B (en) Nanoemulsion
ZA201008829B (en) Nucleoside cyclicphosphates
EP2280616A4 (en) BODY FOR BABY
GB0904436D0 (en) Engagement arrangement
IL213573A0 (en) Lyophilised dabigatran
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
TWI368572B (en) Printing-table arrangement
GB0812597D0 (en) Modified surfaces
GB0815068D0 (en) Insectical combinations
GB0804721D0 (en) Enzyme
EP2012771A4 (en) VACCINES BASED ON NANOEMULSION
GB0803628D0 (en) Enzyme
ZA201104724B (en) Improved bolus
GB0804722D0 (en) Enzyme
GB0800161D0 (en) Rota-board
GB2463042B (en) Stabalizer arrangement
GB0823130D0 (en) Construction member
GB201108463D0 (en) Nanoemulsions
ZA201104218B (en) Lyophilised dabigatran
AU3935P (en) DPV308 Dianella prunina
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed